These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 11350293

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hepatic subcapsular steatosis in a diabetic CAPD patient receiving intraperitoneal insulin.
    Jang EC, Kim G, Kim YS, Yoon SA, Ku YM, Yang CW, Kim YO.
    Korean J Intern Med; 2006 Sep; 21(3):206-9. PubMed ID: 17017674
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rare presentation of subcapsular hepatic steatosis in a woman with uncontrolled diabetes without peritoneal dialysis: a case report.
    Chowdhary V, Pernicka JS, Sharma R.
    J Med Case Rep; 2016 Dec 20; 10(1):370. PubMed ID: 27998312
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Subcapsular fatty infiltration of the liver in peritoneal dialysis patients treated with intraperitoneal insulin: US and CT features (case report)].
    Oğuzkurt L, Hürcan CE, Torun D, Yildirim T.
    Tani Girisim Radyol; 2004 Sep 20; 10(3):242-5. PubMed ID: 15470629
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Subcutaneous versus intraperitoneal insulin in the management of diabetics on CAPD: a review.
    Tzamaloukas AH, Oreopoulos DG.
    Adv Perit Dial; 1991 Sep 20; 7():81-5. PubMed ID: 1680463
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
    Nevalainen P, Lahtela JT, Mustonen J, Pasternack A.
    Nephrol Dial Transplant; 1997 Jan 20; 12(1):145-50. PubMed ID: 9027790
    [Abstract] [Full Text] [Related]

  • 16. The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD.
    Nevalainen PI, Lahtela JT, Mustonen J, Taskinen MR, Pasternack A.
    Perit Dial Int; 1999 Jan 20; 19(2):148-53. PubMed ID: 10357186
    [Abstract] [Full Text] [Related]

  • 17. Decreasing insulin requirements in CAPD patients given intraperitoneal insulin.
    Grefberg N, Danielson BG, Berne C.
    J Diabet Complications; 1987 Jan 20; 1(1):16-9. PubMed ID: 2968990
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.